Triquilar 21

Quick links

Choose a section

Quick links to important sections

Advertisements
Advertisements

Overview of Triquilar 21

What is Triquilar 21?

Triquilar 21 is an oral contraceptive pill used to prevent pregnancy. It is classified as a combined oral contraceptive because it contains two types of female hormones: an estrogen and a progestogen. Specifically, it utilizes a combination of ethinylestradiol and levonorgestrel.

Triphasic Composition

This medication is characterized by its triphasic formulation. Unlike monophasic pills, which provide a constant level of hormones throughout the active cycle, the hormonal dosage in Triquilar 21 changes in three distinct phases over the 21-day period. This design is intended to mimic the natural hormonal fluctuations of the menstrual cycle.

Mechanism of Action

Triquilar 21 prevents pregnancy through several biological mechanisms:

  • Inhibition of Ovulation: The primary function is to suppress the release of an egg from the ovaries during the monthly cycle.
  • Cervical Mucus Alteration: It increases the thickness of the cervical mucus, making it more difficult for sperm to enter the uterus.
  • Endometrial Changes: It alters the lining of the uterus (endometrium), which makes the environment less receptive to the implantation of a fertilized egg.

Presentation

Each blister pack contains 21 active tablets. Each phase of the 21-day cycle is represented by a different color of tablet, indicating the specific hormone ratio for that stage of the regimen. Following the completion of the 21 tablets, a 7-day break is observed, during which a withdrawal bleed typically occurs.

Regulatory References

  1. Ethinyl Estradiol and Levonorgestrel (Oral Contraceptives)
  2. Contraceptive Benefits and Risks - NCBI - NIH
Advertisements

What side effects are possible with Triquilar 21?

Possible side effects and safety information

Official regulatory documents classify the safety profile of Triquilar 21 (Levonorgestrel/Ethinyl Estradiol) based on the frequency and severity of documented adverse reactions. The information below reflects the authoritative safety classification and restrictions established in regulatory labeling.


Frequency-Classified Adverse Reactions

The full spectrum of possible effects is organized by the physiological system affected (System-Organ-Class). Frequently reported reactions include Headache and Breast tenderness, which are often classified as Very Common in official labeling. Reactions commonly reported include Nausea, Abdominal pain, Weight increase, Mood changes, and Breakthrough bleeding or Spotting.

Less frequently documented effects, classified as Uncommon, include Fluid retention, Hypertension, and skin reactions such as Rash and Chloasma (melasma).


Serious Adverse Reactions and Safety Constraints

The most clinically serious safety risk involves Venous Thromboembolism (VTE) and Arterial Thromboembolism (ATE) (e.g., Deep Vein Thrombosis, Pulmonary Embolism, Stroke, or Myocardial Infarction), which are typically classified as Rare. The official safety profile also includes a documented association with certain malignancies, such as Breast and Cervical cancer, and Hepatic tumors.

Use is subject to strict safety restrictions defined in labeling. These constraints prohibit use in individuals with a history of or current VTE/ATE, known or suspected hormone-sensitive cancers, or active liver disease. Furthermore, irregular bleeding may be more frequent during the first three months of use, and the risk of VTE is noted as highest during the first year of combined oral contraceptive use.

Advertisements

Overdose and Emergency Response

Triquilar 21 Overdose and When to Seek Help

The official regulatory profile for Triquilar 21 (Levonorgestrel and Ethinyl Estradiol) overdose emphasizes its low acute toxicity. Ingestion of an excessive amount of this combined oral contraceptive is not typically associated with serious adverse effects and is generally considered non-life-threatening by regulatory documents. The documented clinical signs following an acute overdose primarily relate to the physiological effects of excess steroid hormones. These manifestations include nausea, vomiting, headache, and breast tenderness. A common finding is withdrawal bleeding (vaginal bleeding), which may occur several days after the ingestion. A specific regulatory note indicates that this withdrawal bleeding may also manifest in females, including prepubescent girls, who have accidentally ingested the tablets.

Management of a suspected overdose is required to be symptomatic and supportive, as no specific antidote is known for the combination of Levonorgestrel and Ethinyl Estradiol. Clinical observation and monitoring may be necessary to assess the patient's condition. The official guidance from regulatory authorities mandates that patients must seek immediate medical attention or contact emergency services if an overdose is suspected or if any severe, unexpected, or persistent symptoms occur following the ingestion of an excessive amount of this medication.

Advertisements

Therapeutic Uses of Triquilar 21

What Triquilar 21 Treats: Main Uses and Benefits

The fundamental role of Triquilar 21 is to provide scheduled conception control for women of reproductive potential. The medication is used to prevent pregnancy, offering a supportive method for women to assist with reproductive planning and manage family planning needs.

Beyond its primary use, this combination is generally considered relevant for easing symptom clusters that may become intense or disruptive in conditions influenced by hormone levels. It is applied in clinical settings to help manage menstrual pain (dysmenorrhea), assist with the reduction of heavy menstrual bleeding (HMB), and support patients dealing with hormonal acne breakouts. This therapeutic support helps improve day-to-day comfort by stabilizing the menstrual pattern and assisting with establishing a more regular and predictable cycle.

Quick Fact: Support for Menstrual Symptoms

“This oral contraceptive assists with maintaining functional stability and supports the patient during symptomatic periods related to cycle irregularity or discomfort.”

This support for hormonally influenced conditions may be relevant for easing symptomatic manifestations in gynecological disorders like Polycystic Ovary Syndrome (PCOS).

Regulatory References

  1. NPS MedicineWise (Australia)
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Triquilar 21? (Regulatory Eligibility)

This section defines the official patient eligibility and non-eligibility criteria for Triquilar 21 (levonorgestrel/ethinyl estradiol), as strictly documented in government regulatory prescribing information (e.g., FDA, Health Canada).


Approved Population:

  • Females of reproductive potential for the purpose of prevention of pregnancy.

Contraindications (Must Not Use):

Official regulatory documents explicitly prohibit the use of Triquilar 21 in several high-risk populations, primarily due to the increased risk of blood clots and cardiovascular events:

  • Smokers over 35 years of age.
  • Known or suspected pregnancy.
  • History of deep-vein thrombosis or other thromboembolic disorders.
  • Current or history of cerebrovascular disease or coronary artery disease.
  • History of migraine headaches with focal aura.
  • Active liver disease, decreased liver function, or history of hepatic adenomas/carcinomas.
  • Known or suspected breast carcinoma or other estrogen-dependent neoplasia.
  • Severe hypertension or diabetes mellitus with vascular involvement.

Population-Specific Limitations:

  • Lactation: Use is not recommended while breastfeeding as it may decrease milk production.
  • Geriatric Use: The medication is not indicated for use in postmenopausal women.
Advertisements

What should I know about interactions with other medicines?

Triquilar 21 (ethinyl estradiol and levonorgestrel) may interact with various medicines, which can potentially decrease its contraceptive effectiveness or increase the risk of side effects. It is critical to inform your healthcare provider of all prescription and non-prescription drugs, herbal remedies, and supplements you are taking.

Medicines that May Reduce Triquilar 21 Effectiveness

Several classes of medicines can lower the concentration of the hormones in Triquilar 21, leading to a risk of unintended pregnancy. These include, but are not limited to:

Medicine Class Examples
Anticonvulsants Phenytoin, Carbamazepine, Phenobarbital
Tuberculosis drugs Rifampin, Rifabutin
HIV/AIDS medications Certain protease inhibitors (e.g., ritonavir-containing regimens)
Antibiotics Penicillins and Tetracyclines (efficacy reduction is a topic of ongoing review, but additional barrier methods are often recommended)
Herbal Supplements St. John's wort (Hypericum perforatum)

If you are taking any of these agents, an additional, reliable non-hormonal barrier method of contraception, such as condoms, should be used for the duration of the interacting medicine's use and for a period afterward, as advised by your doctor.

Interactions Causing Increased Side Effects

Triquilar 21 can also affect the concentration of other drugs. For instance, it may increase the levels of certain drugs in the body, such as:

  • Cyclosporine
  • Certain tricyclic antidepressants
  • Corticosteroids (e.g., Prednisolone)

Additionally, the use of certain combination antiviral drugs for treating Hepatitis C (specifically those containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir) is generally contraindicated with Triquilar 21 due to the risk of significant liver enzyme elevations.

Grapefruit juice may also interact with hormonal contraceptives. Always consult your doctor or pharmacist about any new medication before starting it.

Advertisements

Mechanism of Action

Central HPO Axis Inhibition

The mechanism of Triquilar 21 relies on the agonists levonorgestrel (progestin) and ethinyl estradiol (estrogen) binding to their respective receptors in the hypothalamus and pituitary gland. This binding establishes a sustained negative feedback loop that suppresses the release of Gonadotropin-Releasing Hormone (GnRH). The resulting drop in pituitary secretion of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) prevents the necessary LH surge.

Peripheral Alterations

This central suppression results in the core physiological change of inhibition of ovulation (anovulation). Concurrently, the progestin component acts locally on reproductive tissues. It modifies the glandular secretions of the cervix, transforming the fluid into a thick, impermeable physical barrier that impedes sperm transport. Furthermore, it alters the cellular structure of the endometrium (uterine lining), causing it to become thin and unreceptive, establishing a secondary, redundant physiological mechanism.

Advertisements

Dosage and Administration Information

Administration Protocol: Triphasic Cyclic Dosing

Triquilar 21 is a tablet administered orally once daily, according to a continuous 28-day cyclic regimen. The primary goal of the usage instruction is to ensure that the sequential dosage of the triphasic formulation is strictly followed to maintain the established hormonal pattern.


Official Dosing Rules and Schedule

Usage Entity Map Official Labeled Instruction
Route of Administration Oral
Dosing Schedule One tablet daily for 21 consecutive days, followed by a 7-day hormone-free interval.
Timing in Relation to Meals May be taken with or without food.
Special Procedural Conditions Tablets must be taken at approximately the same time every day and in the specific sequential order indicated on the package.

Dosing Initiation and Missed Dose Principles

For the first cycle, the regimen typically starts on the first day of menstruation (Day 1 Start). Following the completion of the 21 active tablets, a new pack is initiated after the 7-day hormone-free interval, continuing the cycle regardless of the presence of withdrawal bleeding.

If an active tablet is missed, the patient must use additional non-hormonal back-up contraception (such as a barrier method) for at least seven consecutive days after resuming the active tablets, as failing to adhere to the daily schedule increases the potential for pregnancy.

Advertisements

Recent Clinical Evidence

Recent Clinical Evidence: Triquilar 21

Triquilar 21 is a triphasic combined oral contraceptive containing the hormones ethinyl estradiol (an estrogen) and levonorgestrel (a progestin). The triphasic nature means the dose of levonorgestrel changes in three phases across the 21-day cycle, while the ethinyl estradiol dose remains consistent or changes only slightly, to closely mimic the body's natural hormonal fluctuations.


Efficacy and Contraceptive Reliability

Clinical trials have established that when used correctly and consistently, combined oral contraceptives like Triquilar 21 are highly effective in preventing pregnancy. These products primarily work by inhibiting the monthly release of an egg from the ovaries (ovulation) and by altering the cervical mucus, which can make it more difficult for sperm to reach the egg.

Observed effectiveness rates in perfect-use clinical trials typically exceed 99%. However, typical use (accounting for missed doses or errors) results in lower effectiveness rates in real-world settings.


Common Adverse Events and Safety Profile

Studies comparing triphasic pills to older monophasic (fixed-dose) preparations have evaluated bleeding patterns and tolerability. Research suggests that triphasic formulations may lead to improved cycle control and reduced instances of unscheduled bleeding compared to some older monophasic options.

Common adverse events reported in clinical data, which are generally associated with combined oral contraceptives, include:

  • Nausea and/or vomiting
  • Headache, including migraine
  • Breast tenderness or pain
  • Changes in body weight or appetite

Important Safety Information

Note on Risk: The use of all combined hormonal contraceptives is associated with a small, increased risk of venous thromboembolism (VTE), or blood clots. This risk is typically highest during the first year of initial use. Patients considering this medication should discuss all individual risk factors, such as age, smoking history, and pre-existing conditions, with a healthcare provider.

Key Studies & References

  1. A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives
  2. Oral Contraceptive Pills (Efficacy, Mechanism, Adverse Effects) - StatPearls [Internet] - NIH
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Triquilar 21 (FAQ)

Q: What is the function of the 7 inactive pills in the pack?

The pack contains 21 active hormone-containing pills and 7 pills that contain no hormones. According to official instructions, these inactive pills are included to help the patient maintain the daily habit of taking one tablet during the 7-day hormone-free interval.

Q: Can Triquilar 21 be used by someone with acne concerns?

The sole purpose of Triquilar 21 documented in its official labeling is the prevention of pregnancy. Acne has been reported in clinical data as both a side effect (adverse event) or as an observed effect when used for its primary purpose.

Q: How long does it typically take for Triquilar 21 to start working?

Official instructions advise that when starting the medication, the body may require at least 7 days to adjust before pregnancy prevention is fully effective. Official instructions state that an additional non-hormonal barrier method is used during this initial 7-day period of the first cycle.

Q: Can Triquilar 21 affect my vitamin or nutrient levels?

Studies have examined the effect of combined oral contraceptives on the metabolism of certain nutrients and B vitamins. While some changes in lab values may be observed, official information does not establish that routine supplementation is necessary for all users.

Q: Does official information say Triquilar 21 changes hair loss or growth?

Official information describes that changes in body or facial hair growth or hair loss have been observed as possible side effects associated with the use of hormonal contraceptives in this class.

Q: Is the return to normal fertility immediate after stopping Triquilar 21?

The return of fertility is generally expected in the first cycle after stopping the pill. Official information notes that about half of women who stop using the pill become pregnant within the first three months, and most within 12 months.

Q: Do official prescribing documents describe any impact on eyesight from Triquilar 21?

Prescribing documents note that sudden changes or loss of vision can be a sign of a serious event, such as a blood clot, which is described in the regulatory document as requiring immediate attention. Additionally, contact lens discomfort has been reported as a possible side effect.

Q: Is Triquilar 21 a commonly prescribed oral contraceptive?

Triquilar 21 is a specific brand of combined oral contraceptive (COC). The active ingredients, levonorgestrel and ethinyl estradiol, are widely used in various hormonal contraceptive forms globally and are included in the World Health Organization's List of Essential Medicines.

Q: Are there specific instructions for what to do if I feel nauseous after starting Triquilar 21?

Nausea is classified as a common adverse event. Administration instructions state the tablet may be taken with or without food. Official information states that if this side effect persists or is severe, it should be reported to a healthcare professional.

Q: How is Triquilar 21 different from other combination pills?

Triquilar 21 is a triphasic combined oral contraceptive. This means the amount of the progestin hormone levonorgestrel changes in three distinct phases over the 21 active days, unlike monophasic pills where the hormone dose remains the same each day.

Q: Is it acceptable to take Triquilar 21 if I also use herbal supplements?

Regulatory documents describe that patients are advised to inform their healthcare provider if they are taking any medicinal products, including dietary supplements and herbal remedies. This is because some of these substances may interact with the medicine, potentially reducing its effectiveness.

Q: Can Triquilar 21 be taken by women who are over the age of 35?

Use of this medication is contraindicated (prohibited) for women over the age of 35 who smoke, due to a significantly increased risk of serious cardiovascular events. Official documents require consultation with a healthcare provider regarding use in other cases.

Q: Can Triquilar 21 be prescribed to women who smoke?

Use of this medication is contraindicated (prohibited) for women over the age of 35 who smoke, due to an increased risk of serious cardiovascular events. Official documents require consultation with a healthcare provider regarding use in other cases.

Q: What does the term 'triphasic' mean when describing this pill?

The term triphasic means that the concentration of the hormones, particularly levonorgestrel, is varied across three distinct phases within the 21-day cycle of active tablets.

Q: Is there any difference between Triquilar 21 and the 28-day pack?

Both the 21-day and 28-day packs contain the same 21 active hormone-containing tablets. The key difference is that the 28-day pack includes seven inactive (non-hormonal) pills intended to help maintain the daily routine during the 7-day hormone-free interval.

Q: Are there specific food items or beverages that interact with Triquilar 21?

Official warnings describe that the beverage Grapefruit juice may increase the blood levels of the active ingredients in the medication. Regulatory guidance describes the importance of discussing any significant dietary changes with a healthcare provider.

Q: What is the difference between the active and inactive pills in the Triquilar 21 pack?

The active pills (21) contain the two steroid hormones, levonorgestrel and ethinyl estradiol. The inactive pills (7) are meant to be taken during the 7-day hormone-free interval and contain no active medicinal ingredients.

Q: Can I take Triquilar 21 if I have a history of migraines?

Official documents state that use of this medication is contraindicated (prohibited) if you have a history of migraine headaches with focal aura. Official information states that any history of migraines necessitates review by a healthcare professional.

Q: What is the role of levonorgestrel in Triquilar 21?

Levonorgestrel is the progestin component of the pill. Its function, along with the estrogen component, is to suppress the monthly release of an egg (ovulation), thicken the cervical mucus to impede sperm movement, and alter the lining of the uterus (endometrium).

Advertisements

How should Triquilar 21 be stored and disposed of?

Storage Conditions

Triquilar 21 tablets must be stored at room temperature, specifically below 30°C (86°F), and kept in a cool, dry place. The medication must be protected from moisture, excessive heat, and direct sunlight.

To ensure product stability, the tablets must remain in the original blister pack until the time of use. For safety, the product labeling requires the medication to be kept out of the reach and sight of children and pets.

Disposal Instructions

Unused or expired Triquilar 21 must not be disposed of in household waste or wastewater. Official regulatory instructions state that patients should return any unused or expired product to a pharmacist or medical institution for proper disposal, in accordance with local requirements for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Triquilar 21 found in:

A-Z Index: